Targeted neutralizing IgY antibodies against SGLT1 glucose transporter reduce glucose uptake and improve glycemic profile in vivo
U. Saxena, K. Meher, A. Reddy RN, G. Kadiyala, S. Iyer, S. Vangala, S. Chandran
bioRxiv · May 6, 2023 · PreprintPharmacology & Toxicology